​

Arcadia Biosciences (RKDA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

RKDA Stock Forecast

Arcadia Biosciences (RKDA) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 37.30% increase from the last price of $4.37.

High: $6 Avg: $6 Low: $6 Last Closed Price: $4.37

RKDA Stock Rating

Arcadia Biosciences stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (80.00%), 1 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 1 4 Strong Sell Sell Hold Buy Strong Buy

RKDA Price Target Upside V Benchmarks

TypeNameUpside
StockArcadia Biosciences37.30%
SectorBasic Materials Stocks 12.25%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$4.37$4.37$4.37
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 25-1---1
Jun, 25-1---1
May, 25-1---1
Apr, 25-1---1
Mar, 25-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 23, 2024Raghuram SelvarajuH.C. Wainwright$6.00$2.78115.83%37.30%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 23, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-90 $-72 $-54 $-36 $-18 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-24.20$-30.33$-26.05$-11.30$-5.16--
Avg Forecast$-85.20$-23.60$-26.40$-9.73$-1.10$-2.82$-2.19
High Forecast$-84.36$-23.37$-26.31$-9.73$-1.10$-2.82$-2.19
Low Forecast$-86.04$-23.83$-26.49$-9.73$-1.10$-2.82$-2.19
Surprise %-71.60%28.52%-1.33%16.14%369.09%--

Revenue Forecast

$2M $4M $6M $8M $10M $12M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$8.03M$6.78M$9.96M$5.33M$5.04M--
Avg Forecast$2.16M$7.94M$11.00M$6.25M$4.98M$6.50M$7.90M
High Forecast$2.18M$8.00M$11.03M$6.25M$4.98M$6.50M$7.90M
Low Forecast$2.14M$7.88M$10.97M$6.25M$4.98M$6.50M$7.90M
Surprise %271.94%-14.62%-9.49%-14.72%1.31%--

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-6.03M$-16.13M$-15.61M$-13.98M$-7.04M--
Avg Forecast$-105.39M$-29.19M$-32.66M$-12.03M$-1.36M$-3.49M$-2.71M
High Forecast$-104.35M$-28.90M$-32.54M$-12.03M$-1.36M$-3.49M$-2.71M
Low Forecast$-106.43M$-29.48M$-32.77M$-12.03M$-1.36M$-3.49M$-2.71M
Surprise %-94.28%-44.73%-52.19%16.23%417.26%--

RKDA Forecast FAQ

Is Arcadia Biosciences stock a buy?

Arcadia Biosciences stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Arcadia Biosciences is a favorable investment for most analysts.

What is Arcadia Biosciences's price target?

Arcadia Biosciences's price target, set by 5 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 37.30% change from the previous closing price of $4.37.

How does Arcadia Biosciences stock forecast compare to its benchmarks?

Arcadia Biosciences's stock forecast shows a 37.30% upside, outperforming the average forecast for the basic materials stocks sector (12.25%).

What is the breakdown of analyst ratings for Arcadia Biosciences over the past three months?

  • July 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Arcadia Biosciences’s EPS forecast?

Arcadia Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.82, marking a -45.35% decrease from the reported $-5.16 in 2024. Estimates for the following years are.

What is Arcadia Biosciences’s revenue forecast?

Arcadia Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $6.5M, reflecting a 28.84% increase from the reported $5.04M in 2024. The forecast for.

What is Arcadia Biosciences’s net income forecast?

Arcadia Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-3.488M, representing a -50.44% decrease from the reported $-7.038M in 2024. Projections indicate .